发明授权
US6001975A Precursor processed to at least one tumor rejection antigen presented by
HLA-A2
失效
前体加工成由HLA-A2呈递的至少一种肿瘤排斥抗原
- 专利标题： Precursor processed to at least one tumor rejection antigen presented by HLA-A2
- 专利标题（中）： 前体加工成由HLA-A2呈递的至少一种肿瘤排斥抗原
-
申请号： US33881申请日： 1998-03-03
-
公开(公告)号： US6001975A公开(公告)日： 1999-12-14
- 发明人: Vincent Brichard , Aline Van Pel , Catia Traversari , Thomas Wolfel , Thierry Boon-Falleur , Etienne De Plaen
- 申请人： Vincent Brichard , Aline Van Pel , Catia Traversari , Thomas Wolfel , Thierry Boon-Falleur , Etienne De Plaen
- 申请人地址： NY New York
- 专利权人： Ludwig Institute for Cancer Research
- 当前专利权人： Ludwig Institute for Cancer Research
- 当前专利权人地址： NY New York
- 主分类号： C07K14/47
- IPC分类号： C07K14/47 ; G01N33/574 ; C07K16/00 ; C07K16/18 ; C07K16/28 ; C07K16/30
摘要：
The invention relates to nucleic acid molecules coding for a tumor rejection antigen precursor. Specifically, the tumor rejection antigen precursor, or `TRAP", is processed into at least one tumor rejection antigen, which is presented by HLA-A2 molecules. Ramifications of the discovery are also set forth.
公开/授权文献
- US5638970A Child-resistant indicator cap 公开/授权日：1997-06-17
信息查询
